15
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Asenapine
Asenapine will be administered open-label in pill form. Asenapine will be initiated at 5 mg twice a day and increased as tolerated to a maximum of 20 mg/day. It is anticipated that maximum stable dosing will be achieved by 4 weeks of treatment, although dosage may be reduced due to tolerability concerns at the discretion of the treating research psychiatrist.
University Hospitals Case Medical Center, Cleveland
Case Western Reserve University
OTHER
University Hospitals Cleveland Medical Center
OTHER